| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.069 | 0.03 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | tubastatin A | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |